- Nourish raises $100M for virtual nutrition careNourish, a telehealth platform that arranges virtual appointments with nutritionists, just raised a new round that bumped its valuation to $1.75 billion, according to a person familiar with the mat…Endpoints · 2mo ago↗ source
- Relay's PI3Kα inhibitor clears efficacy bar in Phase 2 vascular anomalies studyRelay Therapeutics’ first data readout for zovegalisib in a rare genetic disease beat Wall Street expectations, expanding the PI3Kα inhibitor’s R&D prospects beyond breast cancer. The biotech…Endpoints · 2mo ago↗ source
- BioMarin's rare disease therapy shows no clinical benefit in Phase 3 testBioMarin’s enzyme replacement therapy for a rare genetic disorder called ENPP1 deficiency delivered mixed results in a late-stage study. Patients with the condition don't produce enough of the EN…